BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34388372)

  • 1. A midbrain dynorphin circuit promotes threat generalization.
    Fellinger L; Jo YS; Hunker AC; Soden ME; Elum J; Juarez B; Zweifel LS
    Curr Biol; 2021 Oct; 31(19):4388-4396.e5. PubMed ID: 34388372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optogenetic stimulation of dynorphinergic neurons within the dorsal raphe activate kappa opioid receptors in the ventral tegmental area and ablation of dorsal raphe prodynorphin or kappa receptors in dopamine neurons blocks stress potentiation of cocaine reward.
    Abraham AD; Casello SM; Land BB; Chavkin C
    Addict Neurosci; 2022 Mar; 1():. PubMed ID: 36176476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maladaptive behavioral regulation in alcohol dependence: Role of kappa-opioid receptors in the bed nucleus of the stria terminalis.
    Erikson CM; Wei G; Walker BM
    Neuropharmacology; 2018 Sep; 140():162-173. PubMed ID: 30075159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. κ Opioid Receptor-Dynorphin Signaling in the Central Amygdala Regulates Conditioned Threat Discrimination and Anxiety.
    Baird MA; Hsu TY; Wang R; Juarez B; Zweifel LS
    eNeuro; 2021; 8(1):. PubMed ID: 33323398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the kappa opioid receptor in the dorsal raphe nucleus mediates the aversive effects of stress and reinstates drug seeking.
    Land BB; Bruchas MR; Schattauer S; Giardino WJ; Aita M; Messinger D; Hnasko TS; Palmiter RD; Chavkin C
    Proc Natl Acad Sci U S A; 2009 Nov; 106(45):19168-73. PubMed ID: 19864633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presynaptic inhibition of gamma-aminobutyric acid release in the bed nucleus of the stria terminalis by kappa opioid receptor signaling.
    Li C; Pleil KE; Stamatakis AM; Busan S; Vong L; Lowell BB; Stuber GD; Kash TL
    Biol Psychiatry; 2012 Apr; 71(8):725-32. PubMed ID: 22225848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The avBNST
    Li R; Tang G; Yang J; Gao S; Wang Y; Wu X; Bai Y; Liu J
    Neurochem Int; 2024 May; 175():105720. PubMed ID: 38458538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recapitulating phenotypes of alcohol dependence via overexpression of Oprk1 in the ventral tegmental area of non-dependent TH::Cre rats.
    Lepreux G; Shinn GE; Wei G; Suko A; Concepcion G; Sirohi S; Soon Go B; Bruchas MR; Walker BM
    Neuropharmacology; 2023 May; 228():109457. PubMed ID: 36764577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. κ-Opioid Receptor Activation in Dopamine Neurons Disrupts Behavioral Inhibition.
    Abraham AD; Fontaine HM; Song AJ; Andrews MM; Baird MA; Kieffer BL; Land BB; Chavkin C
    Neuropsychopharmacology; 2018 Jan; 43(2):362-372. PubMed ID: 28649993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kappa Opioid Receptor-Induced Aversion Requires p38 MAPK Activation in VTA Dopamine Neurons.
    Ehrich JM; Messinger DI; Knakal CR; Kuhar JR; Schattauer SS; Bruchas MR; Zweifel LS; Kieffer BL; Phillips PE; Chavkin C
    J Neurosci; 2015 Sep; 35(37):12917-31. PubMed ID: 26377476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optogenetic stimulation of lateral hypothalamic orexin/dynorphin inputs in the ventral tegmental area potentiates mesolimbic dopamine neurotransmission and promotes reward-seeking behaviours.
    Thomas CS; Mohammadkhani A; Rana M; Qiao M; Baimel C; Borgland SL
    Neuropsychopharmacology; 2022 Feb; 47(3):728-740. PubMed ID: 34663867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Females are less sensitive than males to the motivational- and dopamine-suppressing effects of kappa opioid receptor activation.
    Conway SM; Puttick D; Russell S; Potter D; Roitman MF; Chartoff EH
    Neuropharmacology; 2019 Mar; 146():231-241. PubMed ID: 30528327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress decreases serotonin tone in the nucleus accumbens in male mice to promote aversion and potentiate cocaine preference via decreased stimulation of 5-HT
    Fontaine HM; Silva PR; Neiswanger C; Tran R; Abraham AD; Land BB; Neumaier JF; Chavkin C
    Neuropsychopharmacology; 2022 Mar; 47(4):891-901. PubMed ID: 34564712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynorphin Controls the Gain of an Amygdalar Anxiety Circuit.
    Crowley NA; Bloodgood DW; Hardaway JA; Kendra AM; McCall JG; Al-Hasani R; McCall NM; Yu W; Schools ZL; Krashes MJ; Lowell BB; Whistler JL; Bruchas MR; Kash TL
    Cell Rep; 2016 Mar; 14(12):2774-83. PubMed ID: 26997280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system.
    Land BB; Bruchas MR; Lemos JC; Xu M; Melief EJ; Chavkin C
    J Neurosci; 2008 Jan; 28(2):407-14. PubMed ID: 18184783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Big dynorphin as a putative endogenous ligand for the kappa-opioid receptor.
    Merg F; Filliol D; Usynin I; Bazov I; Bark N; Hurd YL; Yakovleva T; Kieffer BL; Bakalkin G
    J Neurochem; 2006 Apr; 97(1):292-301. PubMed ID: 16515546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynorphin/Kappa Opioid Receptor Activity Within the Extended Amygdala Contributes to Stress-Enhanced Alcohol Drinking in Mice.
    Haun HL; Lebonville CL; Solomon MG; Griffin WC; Lopez MF; Becker HC
    Biol Psychiatry; 2022 Jun; 91(12):1019-1028. PubMed ID: 35190188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic cellular and circuit contributions to kappa opioid receptor mediated aversion.
    Margolis EB; Karkhanis AN
    Neurochem Int; 2019 Oct; 129():104504. PubMed ID: 31301327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kappa opioid inhibition of somatodendritic dopamine inhibitory postsynaptic currents.
    Ford CP; Beckstead MJ; Williams JT
    J Neurophysiol; 2007 Jan; 97(1):883-91. PubMed ID: 17122312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRF1-R activation of the dynorphin/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior.
    Bruchas MR; Land BB; Lemos JC; Chavkin C
    PLoS One; 2009 Dec; 4(12):e8528. PubMed ID: 20052275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.